Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 2016 (2016), Article ID 3915237, 13 pages
Review Article

Noninvasive Positive Pressure Ventilation in Chronic Heart Failure

1Department of Cardiovascular Diseases, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
3Renal Division and Molecular Cell Laboratory for Kidney Disease, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Received 3 June 2016; Revised 22 August 2016; Accepted 4 October 2016

Academic Editor: Zhongheng Zhang

Copyright © 2016 Hao Jiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Instruction and Objectives. Noninvasive positive pressure ventilation (NPPV) alleviates sleep-disordered breathing (SDB) and it may improve cardiac function in SDB patients. Because large randomized controlled trials directly evaluating the impact of NPPV on cardiac function are lacking, we conducted a meta-analysis of published data on effectiveness of NPPV in improving cardiac function in patients with chronic heart failure regardless of SDB presence. Methods. Controlled trials were identified in PubMed, OVID, and EMBASE databases. Both fixed and randomized models were used in meta-analysis with primary outcomes of left ventricular ejection fraction (LVEF). Results. Nineteen studies were included with a total of 843 patients. Compared to standard medical treatment (SMT) plus sham-NPPV or SMT only, NPPV plus SMT was associated with improvement in LVEF (weighted mean difference 5.34, 95% CI, ; ) and plasma brain natriuretic peptide (BNP) level (weighted mean difference −117.37, 95% CI, ; ) and no influence on overall mortality (RR 1.00, 95% CI, ; ). Conclusions. In the present meta-analysis, use of NPPV plus SMT improved LVEF and reduced plasma BNP level but did not improve overall mortality in patients with chronic heart failure.